Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A. Barbie, William C. Hahn, Qing Sheng et al.|Nature|2009Cited by 4.2k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L. Levine, D. Gary Gilliland, Martha Wadleigh et al.|Cancer Cell|2005Cited by 3k
Small-molecule-induced polymerization triggers degradation of BCL6Mikołaj Słabicki, Benjamin L. Ebert, Hojong Yoon et al.|Nature|2020Cited by 270
Prognostic Impact of Minimal Residual Disease in<i>CBFB-MYH11</i>–Positive Acute Myeloid LeukemiaAndrea Corbacioglu, Konstanze Döhner, Claudia Scholl et al.|Journal of Clinical Oncology|2010Cited by 136
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with <i>PDL1</i> amplificationStefan Gröschel, Stefan Fröhling|Molecular Case Studies|2016Cited by 60